上海创新药械应用示范项目征集合作
我要合作生物医药AI 精选📍 上海市👁 12026-09-26 17:52
上海市科委发布2026年度科技产业高质量发展计划“创新药械产品应用示范”项目申报指南（沪科指南〔2026〕28号），设创新药品应用示范、创新医疗器械应用示范两个专题，支持创新药械产品在医疗机构开展示范应用与推广。机会点在于：项目由医疗机构牵头，但明确要求参与企业须为所应用或研究产品的上市许可持有人或注册人，且产品须在本市实现产出，这意味着上海的创新药械企业必须与牵头医疗机构及课题承担医疗机构组建联合体才能申报，企业端存在明确的合作对接缺口。谁该参与：本市创新药企、医疗器械注册人/上市许可持有人，尤其是产品已取得注册批件和生产许可证、已取得本市收费编码并已进入或即将进入医疗机构用药目录/用械目录的企业；以及具备高级职称课题负责人、有合规示范应用条件的本市医疗机构。怎么参与：由医疗机构科研管理部门组织申报，企业作为参与方需与牵头医疗机构签订合作协议，准备注册批件、生产许可证、III期或确证性临床试验例数证明（专题一方向二还需拓展新适应症临床试验批件）、申报承诺书等附件，通过“上海市科技管理信息系统”网上填报，无需纸质材料。时间窗口：网上填报起始2026年9月29日9:00，截止2026年10月23日16:30（含申报单位网上审核提交），采用一轮通讯评审，立项清单将向社会公示。注意同一药品同一适应症、同一医疗器械同一方向仅支持一次，已获本专项资助的不再支持。
事实依据：上海市科学技术委员会关于发布2026年度科技产业高质量发展计划“创新药械产品应用示范”项目申报指南的通知
English version — Shanghai Innovation Drug and Device Application Demonstration Project Seeks Partners
The Shanghai Municipal Science and Technology Commission issued the 2026 Science and Technology Industry High-Quality Development Plan 'Innovative Drug and Device Product Application Demonstration' project application guidelines (Hu Ke Zhi Nan [2026] No. 28), with two special topics: innovative drug application demonstration and innovative medical device application demonstration, supporting demonstration application and promotion of innovative drug and device products in medical institutions. The opportunity lies in: the project is led by medical institutions, but it explicitly requires participating enterprises to be the marketing authorization holders or registrants of the applied or researched products, and the products must be produced in this city. This means Shanghai's innovative drug and device enterprises must form consortia with lead medical institutions and project-bearing medical institutions to apply, creating a clear partnership matching gap on the enterprise side. Who should participate: Shanghai-based innovative drug companies, medical device registrants/marketing authorization holders, especially those whose products have obtained registration approval and production licenses, have obtained Shanghai charging codes, and have entered or are about to enter medical institution drug/device catalogs; as well as Shanghai medical institutions with senior-title project leaders and compliant demonstration application conditions. How to participate: Applications are organized by medical institution research management departments. Enterprises, as participants, need to sign cooperation agreements with lead medical institutions and prepare